Stimulation of non-specific resistance to tumors in the mouse using a poly(maleic-acid-styrene)-conjugated neocarzinostatin

[1]  Hiroshi Maeda,et al.  A lipophilic derivative of neocarzinostatin. A polymer conjugation of an antitumor protein antibiotic. , 2009, International journal of peptide and protein research.

[2]  H. Maeda,et al.  A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs. , 1986, Cancer research.

[3]  R. Brutkiewicz,et al.  Lack of correlation between antitumour response and serum interferon levels in mice treated with SSM, an immunotherapeutic anticancer agent. , 1986, British Journal of Cancer.

[4]  R. Pollard,et al.  Cooperation of lymphokine(s) and macrophages in expression of antitumor activity of carboxyethylgermanium sesquioxide (Ge-132). , 1986, Anticancer research.

[5]  H. Maeda,et al.  Stimulation of Macrophage by Polyanions and Its Conjugated Proteins and Effect on Cell Membrane 1 , 1986, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[6]  R. Pollard,et al.  Ability of sera from mice treated with Ge-132, an organic germanium compound, to inhibit experimental murine ascites tumours. , 1985, British Journal of Cancer.

[7]  R. Pollard,et al.  Importance of T-cells and macrophages in the antitumor activity of carboxyethylgermanium sesquioxide (Ge-132). , 1985, Anticancer research.

[8]  M. Ueda,et al.  Conjugation of poly(styrene-co-maleic acid) derivatives to the antitumor protein neocarzinostatin: pronounced improvements in pharmacological properties. , 1985, Journal of medicinal chemistry.

[9]  S. Tashiro,et al.  Selective targeting of anti‐cancer drug and simultaneous image enhancement in solid tumors by arterially administered lipid contrast medium , 1984, Cancer.

[10]  Toshimitsu Konno,et al.  Tailor-making of protein drugs by polymer conjugation for tumor targeting: A brief review on smancs , 1984 .

[11]  S. Tashiro,et al.  Effect of arterial administration of high-molecular-weight anticancer agent SMANCS with lipid lymphographic agent on hepatoma: a preliminary report. , 1983, European journal of cancer & clinical oncology.

[12]  R. Pollard,et al.  Alterations of interferon production in a mouse model of thermal injury. , 1982, Journal of immunology.

[13]  R. Ottenbrite.  The Antitumor and Antiviral Effects of Polycarboxylic Acid Polymers , 1982 .

[14]  H. Maeda,et al.  In vitro mode of action, pharmacokinetics, and organ specificity of poly (maleic acid-styrene)-conjugated neocarzinostatin, SMANCS. , 1982, Gan.

[15]  H. Johnson,et al.  Classification of interferons with antibody to immune interferon. , 1980, Cellular immunology.

[16]  D. J. Strydom,et al.  Neocarzinostatin: spectral characterization and separation of a non-protein chromophore. , 1979, Biochemical and biophysical research communications.

[17]  J. L. Crane,et al.  Inhibition of murine osteogenic sarcomas by treatment with type I or type II interferon. , 1978, Journal of the National Cancer Institute.

[18]  T. Merigan,et al.  Nonviral Interferon Inducers , 1970, The Journal of general physiology.

[19]  T. Merigan,et al.  Induction of interferon by nonviral agents. , 1970, Archives of internal medicine.

[20]  T. Merigan,et al.  STRUCTURAL REQUIREMENTS FOR SYNTHETIC POLYANIONS TO ACT AS INTERFERON INDUCERS * , 1970 .

[21]  E. De Clercq,et al.  Antiviral activity of polyacrylic and polymethacrylic acids. I. Mode of action in vitro. , 1968, Journal of virology.

[22]  T. Merigan,et al.  Interferon-stimulating and in vivo antiviral effects of various synthetic anionic polymers. , 1968, Virology.

[23]  T. Merigan.  Induction of Circulating Interferon by Synthetic Anionic Polymers of Known Composition , 1967, Nature.

[24]  H. Maeda,et al.  Interferon induction by SMANCS: a polymer-conjugated derivative of neocarzinostatin. , 1988, Anticancer research.

[25]  H. Maeda,et al.  Targeting Chemotherapy of Hepatocellular Carcinoma , 1987 .

[26]  A. Dolei.  [Interferon and the immune system]. , 1987, Annali dell'Istituto superiore di sanita.

[27]  岩井 顕.  Use of oily contrast medium for selective drug targeting to tumor : enhanced therapeutic effect and X-ray image , 1986 .

[28]  F. Suzuki,et al.  Induction of interferon and activation of NK cells and macrophages in mice by oral administration of Ge-132, an organic germanium compound. , 1985, Microbiology and immunology.

[29]  I. Gresser.  The Antitumor Effects of Interferon in Mice , 1983 .

[30]  H. Maeda.  Neocarzinostatin in cancer chemotherapy (review). , 1981, Anticancer research.

[31]  H. Johnson,et al.  Large-scale production and partial purification of mouse immune interferon. , 1979, Infection and immunity.

[32]  E. De Clercq,et al.  Antiviral activity of polyacrylic and polymethacrylic acids. II. Mode of action in vivo. , 1968, Journal of virology.